Zach Reitano, entrepreneur focused on personalized healthcare, shares how Covid accelerated telemedicine adoption, the importance of building trust with patients, and the impact of Ro's commercial featuring his dad.

Zach Reitano, CEO and co-founder of Ro, a direct-to-patient healthcare company, discusses the challenges in today's healthcare model. He highlights how the system often overlooks patient needs and the importance of focusing on cost, quality, and access. Reitano shares insights into using technology to enhance care and argues that quality should not be equated with time spent. He champions a patient-centric approach, advocating for empowered health choices and innovative financial solutions like healthcare savings accounts to foster autonomy.

Exploring the societal impact of weight-loss drugs like Ozempic, the $7 billion valuation of Ro's CEO, parallels between weight-loss drugs and AI frenzy, strategic shifts in focusing on obesity treatments, transformative effects of GLP drugs and AI on healthcare, patient-centric marketing strategies, and the potential of weight loss drugs in addressing health issues.